Methods |
|
|
Participants |
Exclusion criteria: NS |
|
Interventions | Treatment group
Control group
Duration of follow‐up: NS |
|
Outcomes |
|
|
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | The study did not provide the information on the method of random sequence generation, and only presented with the data as "all participants with nephrotic syndrome were randomly allocated to treatment and control groups". |
Allocation concealment (selection bias) | Unclear risk | The study did not provide the information on allocation concealment. |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | The study did not provide the information on blinding. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | There were no missing data in this study. |
Selective reporting (reporting bias) | High risk | Free of selective reporting bias was assessed as "No" due to some clinically important outcomes unstated, such as adverse effects of polyvalent vaccine. |
Other bias | Unclear risk | There was insufficient information to make judgement. |